New dietary treatment for epilepsy well tolerated and reduced seizures

The first clinical trial of a new dietary treatment for children and adults with severe forms of epilepsy, co-developed by UCL researchers and based on the ketogenic diet, has been successfully completed. For the study, published in Brain Communications, clinicians evaluated the use of K.Vita, (also known as Betashot), an oral liquid dietary supplement developed by UCL in collaboration with […]

Continue reading »

Sinopharms COVID-19 Shot Induces Weaker Antibody Responses to Delta: Study

BEIJING (Reuters) – Sinopharm’s COVID-19 vaccine elicited weaker antibody responses against the Delta variant, based on the first published study of its effect against the more contagious version. Antibodies against the virus receptor-binding domain in people receiving Sinopharm’s BBIBP-CorV vaccine were reduced 1.38-fold against the Delta variant versus an older version of the coronavirus first identified in Wuhan, a lab […]

Continue reading »

Researchers study the role of subnuclear NSrp70 in T cell-mediated adaptive immunity

T cells are components of the body’s immune system. The ability of T cells to recognize diverse pathogens and mount a defense against them stems from the way proteins are spliced during their development and maturation. Now, scientists from Korea highlight the importance of a protein called NSrp70, which was previously discovered in T cell subnuclear spaces, in regulating the […]

Continue reading »

Neuromuscular electrostimulation tested for hand motor recovery in elderly stroke patients

The University of Valencia (UV), in collaboration with FISABIO and the Doctor Peset University Hospital, has conducted a randomized clinical trial comparing the effects of two neuromuscular electrostimulation (EENM) protocols with different frequencies on the motor impairment of the hand in older patients after a stroke. The study looked at whether changes in hand deficits—such as strength or muscle tone—were […]

Continue reading »

US FDA Sets January Target to Decide on Approval of Pfizers COVID-19 Shot

(Reuters) – The U.S. health regulator will review Pfizer and German partner BioNTech’s application for full approval of their COVID-19 vaccine in people 16 years and older by January, the companies said on Friday. The target action date does not mean the approval will not happen before January, the U.S. Food and Drug Administration’s Acting Commissioner Janet Woodcock said on Twitter. […]

Continue reading »

Analysis: Necessary or Not, Covid Booster Shots Are Probably on the Horizon

The drugmaker Pfizer recently announced that vaccinated people are likely to need a booster shot to be effectively protected against new variants of covid-19 and that the company would apply for Food and Drug Administration emergency use authorization for the shot. Top government health officials immediately and emphatically announced that the booster isn’t needed right now — and held firm […]

Continue reading »
1 772 773 774 775 776 1,323